| 創建日期 | 上市日期 | 董事長 | 總經理 |
|---|---|---|---|
| 98/11/27 | 101/10/24 | 李沛霖 | 李沛霖 |
| EPS | 本益比 | 股價淨值比 | 現金殖利率 |
| 0.58(Q2) | 25.78 | 1.51 | 3.51% |
| 實收資本額 | 已發行普通股 | ||
| 1,649,671,360 | 164,967,136 | ||
| 主要經營業務 | |||
| 放射腫瘤、神經科學、影像醫學、眼科及外科/手術等儀器設備銷售維修保養、出租及其相關零配件、耗材之銷售及藥品銷售一般投資業 | |||
| 公司網址 | |||
| chcg.com | |||
承業醫(4164) 月營收報表
| 年度/月份 | 營業收入（單位：千元） | 累計營業收入（單位：千元） | |||||
|---|---|---|---|---|---|---|---|
| 單月營收 | 去年同月營收 | 單月月增率 | 單月年增率 | 累計營收 | 去年累計營收 | 累積年增率 | |
| 2023/08 | 243,833 | 233,463 | 7.5% | 4.4% | 2,157,185 | 1,748,107 | 23.4% |
| 2023/07 | 226,888 | 216,226 | -45.5% | 4.9% | 1,913,352 | 1,514,644 | 26.3% |
| 2023/06 | 416,553 | 191,247 | 68.2% | 117.8% | 1,686,464 | 1,298,418 | 29.9% |
| 2023/05 | 247,672 | 282,544 | 11.6% | -12.3% | 1,269,911 | 1,107,171 | 14.7% |
| 2023/04 | 221,929 | 218,442 | -42.6% | 1.6% | 1,022,239 | 824,627 | 24% |
| 2023/03 | 386,862 | 225,613 | 95% | 71.5% | 800,310 | 606,185 | 32% |
| 2023/02 | 198,428 | 160,945 | -7.7% | 23.3% | 413,448 | 380,572 | 8.6% |
| 2023/01 | 215,020 | 219,627 | -44% | -2.1% | 215,020 | 219,627 | -2.1% |
| 2022/12 | 383,833 | 475,310 | 61.9% | -19.2% | 2,974,352 | 2,441,247 | 21.8% |
| 2022/11 | 237,138 | 216,962 | -0.2% | 9.3% | 2,590,519 | 1,965,937 | 31.8% |
| 2022/10 | 237,549 | 185,963 | -35.4% | 27.7% | 2,353,381 | 1,748,975 | 34.5% |
| 2022/09 | 367,725 | 202,122 | 57.5% | 81.9% | 2,115,832 | 1,563,012 | 35.4% |
| 2022/08 | 233,463 | 145,042 | 8% | 61% | 1,748,107 | 1,360,890 | 28.5% |
| 2022/07 | 216,226 | 131,802 | 13.1% | 64.1% | 1,514,644 | 1,215,848 | 24.6% |
| 2022/06 | 191,247 | 141,842 | -32.3% | 34.8% | 1,298,418 | 1,084,046 | 19.8% |
| 2022/05 | 282,544 | 142,630 | 29.3% | 98.1% | 1,107,171 | 942,204 | 17.5% |
| 2022/04 | 218,442 | 158,515 | -3.2% | 37.8% | 824,627 | 799,574 | 3.1% |
| 2022/03 | 225,613 | 179,481 | 40.2% | 25.7% | 606,185 | 641,059 | -5.4% |
| 2022/02 | 160,945 | 275,764 | -26.7% | -41.6% | 380,572 | 461,578 | -17.5% |
| 2022/01 | 219,627 | 185,814 | -53.8% | 18.2% | 219,627 | 185,814 | 18.2% |
| 2021/12 | 475,310 | 226,715 | 119.1% | 109.7% | 2,441,247 | 2,554,663 | -4.4% |
| 2021/11 | 216,962 | 153,543 | 16.7% | 41.3% | 1,965,937 | 2,327,948 | -15.6% |
| 2021/10 | 185,963 | 154,413 | -8% | 20.4% | 1,748,975 | 2,174,405 | -19.6% |
| 2021/09 | 202,122 | 349,580 | 39.3% | -42.2% | 1,563,012 | 2,019,992 | -22.6% |
| 2021/08 | 145,042 | 176,158 | 10% | -17.7% | 1,360,890 | 1,670,412 | -18.5% |
| 2021/07 | 131,802 | 306,437 | -7.1% | -57% | 1,215,848 | 1,494,254 | -18.6% |
| 2021/06 | 141,842 | 244,227 | -0.6% | -41.9% | 1,084,046 | 1,187,817 | -8.7% |
| 2021/05 | 142,630 | 125,004 | -10% | 14.1% | 942,204 | 943,590 | -0.1% |
| 2021/04 | 158,515 | 263,534 | -11.7% | -39.8% | 799,574 | 818,586 | -2.3% |
| 2021/03 | 179,481 | 148,190 | -34.9% | 21.1% | 641,059 | 555,052 | 15.5% |
| 2021/02 | 275,764 | 281,268 | 48.4% | -2% | 461,578 | 406,862 | 13.4% |
| 2021/01 | 185,814 | 125,594 | -18% | 47.9% | 185,814 | 125,594 | 47.9% |
| 2020/12 | 226,715 | 301,403 | 47.7% | -24.8% | 2,554,663 | 2,950,052 | -13.4% |
| 2020/11 | 153,543 | 155,010 | -0.6% | -0.9% | 2,327,948 | 2,648,649 | -12.1% |
| 2020/10 | 154,413 | 153,667 | -55.8% | 0.5% | 2,174,405 | 2,493,639 | -12.8% |
| 2020/09 | 349,580 | 338,365 | 98.4% | 3.3% | 2,019,992 | 2,339,972 | -13.7% |
承業醫(4164) 歷年營收季增率
| 年度/季別 | 營收季增率 | 近4季營收季增率 | 年度/季別 | 營收季增率 | 近4季營收季增率 |
|---|---|---|---|---|---|
| 2023Q2 | 10.73% | 6.12% | 2020Q3 | 31.51% | -4.02% |
| 2023Q1 | -6.78% | 6.53% | 2020Q2 | 14.00% | -4.66% |
| 2022Q4 | 5.03% | -0.66% | 2020Q1 | -9.02% | -2.57% |
| 2022Q3 | 18.08% | 12.74% | 2019Q4 | -35.26% | -1.74% |
| 2022Q2 | 14.20% | 10.36% | 2019Q3 | 22.92% | 7.50% |
| 2022Q1 | -30.98% | -1.43% | 2019Q2 | 21.49% | 2.15% |
| 2021Q4 | 83.36% | 16.38% | 2019Q1 | -4.74% | 9.04% |
| 2021Q3 | 8.12% | -14.41% | 2018Q4 | -9.60% | 1.96% |
| 2021Q2 | -30.90% | -7.19% | 2018Q3 | 3.52% | 12.38% |
| 2021Q1 | 19.90% | 3.37% | 2018Q2 | 75.09% | 12.53% |
| 2020Q4 | -35.75% | -2.87% | 2018Q1 | -34.19% | -7.98% |
評論0